Clinical Trial Update: Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants [Phase 1]

View source ↗

Summary

Phase 1 study assessing single-dose and multiple-dose intravenous infusions of TNP-2092 in healthy Chinese participants; the trial has completed with status lis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infection
• Prosthetic Joint Infection

Drugs mentioned

• TNP-2092 for Injection (TNP-2092)

Snippet

Sponsor: TenNor Therapeutics Inc. | Conditions: Acute Bacterial Skin and Skin Structure Infection (ABSSSI), Prosthetic Joints Infection (PJI) | Phase 1 | Status: COMPLETED